Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 901–1,000 of 1,000
Using nanobiotechnology to increase the prevalence of epigenotyping assays in precision medicine
Heimer, B. W., Tam, B. E., Minkovsky, A., & Sikes, H. D. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1407 · Cited by 6
Colorectal Cancer Biomarkers in Circulation
Dakubo, G. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-48360-3_7 · Cited by 6
Oncogenic mutations of PIK3CA and HRAS in carcinoma of cervix in South Indian women
Kumari, K. G., Mandarapu, R., & Sudhakar, G. (2017) · Journal of Oncological Sciences · doi:10.1016/j.jons.2017.10.004 · Cited by 5
Liquid biopsy assessment of synchronous malignancies: a case report and review of the literature
Liebs, S., Nonnenmacher, A., Klauschen, F., Keilholz, U., & Vecchione, L. (2019) · ESMO Open · doi:10.1136/esmoopen-2019-000528 · Cited by 5
Xia, P., Meng, Z., Li, J., Xie, J., Ke, Y., Liu, S., Xiao, M., & Chen, Q. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114981 · Cited by 4
Tocci, N. X., Wehrle, C. J., Sun, K., Jiao, C., Hong, H., Gross, A. R., Allkushi, E., Uysal, M., Linganna, M. W., Stackhouse, K., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27825 · Cited by 4
Wesolowski, R., Rugo, H. S., Specht, J. M., Han, H. S., Kabos, P., Vaishampayan, U. N., Wander, S. A., Gogineni, K., Spira, A. I., Schott, A. F., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0992 · Cited by 7
The importance of circulating tumor products as „liquid biopsies” in colorectal cancer
Miscoci, S. A., Pirvu, C., Calborean, V., Streba, C. T., Rogoveanu, O. C., Pădureanu, V., & Vere, C. C. (2018) · Journal of Mind and Medical Sciences · doi:10.22543/7674.51.p3945 · Cited by 4
Adams, A. M., Vreeland, T. J., & Newhook, T. E. (2022) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00888-y · Cited by 4
Circulating tumour DNA in colorectal cancer management
Cohen, R., Platell, C. F. E., McCoy, M. J., Meehan, K. L., & Fuller, K. A. (2023) · British journal of surgery · doi:10.1093/bjs/znad126 · Cited by 5
Hao, M.-J., Cheng, Z., Gao, Y., Xin, L., Yu, C.-T., Wang, T., Li, Z., & Wang, L. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2310167 · Cited by 4
Deligezer, U., Oberhofer, A., Worf, K., Stoetzer, O. J., Holdenrieder, S., & Bronkhorst, A. J. (2024) · Diagnostics · doi:10.3390/diagnostics14060609 · Cited by 4
dos Reis, M. B., dos Santos, W., de Carvalho, A. C., Lima, A. B., Reis, M. T., Santos, F. A., Reis, R. M., & Guimarães, D. P. (2024) · BMC Cancer · doi:10.1186/s12885-024-13287-2 · Cited by 6
Lee, S.-S., Eitzmann, D. R., & Anderson, J. L. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343563 · Cited by 4
Potential of Cell-free Circulating DNA in Diagnosis of Cancer
Kubaczková, V., Sedlaříková, L., Bešše, L., Almáši, M., Hájek, R., & Ševčíková, S. (2015) · Klinicka onkologie · doi:10.14735/amko2015251 · Cited by 4
Genomic approach to translational studies in colorectal cancer
Cheasley, D. A., Jorissen, R. N., Liu, S., Tan, C. W., Love, C. G., Palmieri, M., & Sieber, O. M. (2018) · Translational Cancer Research · doi:10.21037/4524 · Cited by 7
Clonal rolling circle amplification for on-chip DNA cluster generation
Korfhage, C., Fricke, E., Meier, A., Geipel, A., Baltes, M., Krüger, N., Herschel, F., & Erbacher, C. (2017) · Biology Methods and Protocols · doi:10.1093/biomethods/bpx007 · Cited by 4
Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA
Chen, Y., George, A. M., Olsson, E., & Saal, L. H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7778-9_17 · Cited by 4
Randrian, V., Adenis, A., Desrame, J., Barbier, E., Fiore, F. D., Lièvre, A., Dahan, L., Laurent‐Puig, P., Mineur, L., Breysacher, G., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.11.014 · Cited by 4
Extracellular genetic materials and their application in clinical practice
Koçana, C. Ç., Toprak, S. F., & Sözer, S. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.12.006 · Cited by 4
Analysis of cell‐free circulating DNA fragment size and level in patients with lumbar canal stenosis
Hiyama, A., Sakai, D., Nomura, S., Katoh, H., & Watanabe, M. (2021) · JOR Spine · doi:10.1002/jsp2.1189 · Cited by 4
Haselmann, V., Hedtke, M., & Neumaier, M. (2022) · Journal of Laboratory Medicine · doi:10.1515/labmed-2022-0066 · Cited by 4
Pu, W., Wang, F., Li, K., Xing, C., Zhuang, Z., Wang, H., Bian, H., Zhang, R., & Li, X. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04488-9 · Cited by 4
DNA methylation ratio variability may impede clinical application of cancer diagnostic markers
Burke, D. G., Fu, S., Forbes-Smith, M., Bhat, S., Partis, L., Coldham, T., Frenkel, R. B., & Emslie, K. R. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7914-5 · Cited by 4
State of the Art and Future Direction for the Analysis of Cell-Free Circulating DNA
Heliebi, A. E., & Heitzer, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00005-8 · Cited by 5
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer
Zhu, L., Wang, Y., Zhou, Y., Dong, Q., Liu, Y., & Zhang, J. (2020) · BioMed Research International · doi:10.1155/2020/5419634 · Cited by 4
An Emulsion Based Microarray Method to Detect the Toxin Genes of Toxin-Producing Organisms
Wāng, Y., Lu, J., Yang, Q., Bai, Y., & Ge, Q. (2011) · Molecules · doi:10.3390/molecules16097365 · Cited by 4
Blood Plasma Handling for Protein Analysis
Ericsson, C., & Nistér, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-59745-423-0_20 · Cited by 4
Georgiadis, K. L., Simpson, K., Ayub, M., Brady, G., Valle, J. W., Jørgensen, C., & Dive, C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_62-1 · Cited by 4
Future Paradigm of Breast Cancer Resistance and Treatment
Velaga, R., & Sugimoto, M. (2017) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-70142-4_7 · Cited by 5
The Introduction and Clinical Application of Cell-Free Tumor DNA
Li, J., Liu, R., Huang, C., Chen, S., & Xu, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7717-8_4 · Cited by 4
Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort
Shen, H., Li, J., Yao, Y., Yang, Z., Zhou, Y., Chen, W., & Hu, T. (2020) · Cancer Management and Research · doi:10.2147/cmar.s254139 · Cited by 6
Rebuttal from Dr. Mino-Kenudson
Mino-Kenudson, M. A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.08.02 · Cited by 4
Prostate Cancer: Detection of Free Tumor-Specific DNA in Blood and Bone Marrow
Schwarzenbach, H., & Pantel, K. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8442-3_34 · Cited by 4
Colorectal cancer: Application of selected liquid biopsy markers
Skrzypek, M., Binda, A., Kabziński, J., Piotrzkowska, D., Głowacka, M., Dziki, Ł. A., Dziki, A. J., & Majsterek, I. (2025) · Polish Journal of Surgery · doi:10.5604/01.3001.0055.0608 · Cited by 3
Lobo-Castañón, M. J., & Díaz‐Fernández, A. (2025) · Biosensors · doi:10.3390/bios15110726 · Cited by 5
The advances of DNA methylation in the liquid biopsy for the detection of lung cancer
Chen, Y., Peng, S., & Wang, C. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1547797 · Cited by 5
Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules
Patel, K. (2015) · Scholarship@Western (Western University) · Cited by 4
Circulating tumour DNA: a minimally invasive biomarker for tumour detection and stratification
Surani, A. A. (2016) · British Journal of Pharmacy · doi:10.5920/bjpharm.2016.07 · Cited by 4
Potential and Challenges of Liquid Biopsies
Heliebi, A. E., Heitzer, E., Kroneis, T., Chen, S., Haudum, C. W., & Fuchs, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53661-3_12 · Cited by 2
Mouliere, F. C., Thierry, A. R., & Larroque, C. (2014) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-017-9168-7_5 · Cited by 6
Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer
Cornice, J., Capece, D., Nolfi, M. D. V., Padova, M. D., Compagnoni, C., Verzella, D., Francesco, B. D., Vecchiotti, D., Flati, I., Tessitore, A., et al. (2021) · Genes · doi:10.3390/genes12111726 · Cited by 3
LIQUID BIOPSY IN CLINICAL ONCOLOGY
Имянитов, Е. Н., Kuligina, E. S., & Yanus, G. A. (2022) · Practical oncology · doi:10.31917/2304211 · Cited by 2
Maansson, C. T., Andersen, E. R., Ulhøi, M. P., Meldgaard, P., & Sørensen, B. S. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05259-3 · Cited by 3
Wang, M., Xu, T., Shen, L., Li, J., Zhu, L., Wang, C., Hu, Z., Li, P., Yang, Y., & Wang, X. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300044 · Cited by 3
Meriranta, L., Pitkänen, E., & Leppä, S. (2023) · Seminars in Hematology · doi:10.1053/j.seminhematol.2023.06.006 · Cited by 3
Emerging Applications of Liquid Biopsies in Ovarian Cancer
Chauhan, U. S., Kohale, M., Jaiswal, N., & Wankhade, R. (2023) · Cureus · doi:10.7759/cureus.49880 · Cited by 6
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas
Díez-Feijoo, R., Andrade‐Campos, M., Gibert, J., Sánchez‐González, B., Fernández‐Ibarrondo, L., Fernández‐Rodríguez, C., García-Gisbert, N., Camacho, L., Lafuente, M., Vázquez, I., et al. (2024) · Cancers · doi:10.3390/cancers16020321 · Cited by 3
Mirikar, D., Banerjee, N., Prabhash, K., Kumar, R., Naronha, V., Pramesh, C. S., Karimundackal, G., Joshi, A., Rane, S. U., & Basak, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-85160-6 · Cited by 5
Circulating DNA in Cancer Diagnosis and Prognosis
Vietsch, E. E., & Wellstein, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00014-4 · Cited by 3
Horlitz, M., Hartinger, T., Graf, S., Lucas, A., Nocon, A., & Sprenger‐Haussels, M. (2010) · Springer eBooks · doi:10.1007/978-90-481-9382-0_35 · Cited by 3
Sgaramella, V., & Salamini, F. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.03.001 · Cited by 3
Detection of human tumor cells by amplicon fusion site polymerase chain reaction (AFS-PCR)
Weber, A., Taube, S., Starke, S., Bergmann, E., Christiansen, N. M., & Christiansen, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44415 · Cited by 3
Liquid biopsies: advancing cancer research through drops of blood
Khattak, A. (2016) · Internal Medicine Journal · doi:10.1111/imj.12996 · Cited by 3
Hinrichsen, T., Dworniczak, J. K., Wachter, O., Dworniczak, B., & Dockhorn‐Dworniczak, B. (2016) · Journal of Laboratory Medicine · doi:10.1515/labmed-2016-0035 · Cited by 4
Molecular Testing in Lung Cancer
Shiau, C. J., & Tsao, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800886-7.00023-6 · Cited by 3
Circulating tumor DNA—From bench to bedside
Lim, J. S. J., Jankú, F., & Yap, T. A. (2017) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2017.02.005 · Cited by 4
Current Utility and Future Applications of ctDNA in Colorectal Cancer
Day, D., Frentzas, S., Naidu, C. A., Segelov, E., & Green, M. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82316 · Cited by 4
Macedo, F., Monteiro, J. C., Pereira, T. C., Monteiro, A. R., Soares, R. F., Bonito, N., & Sousa, G. (2022) · Gastroenterology and hepatology from bed to bench. · Cited by 3
A Blood-Based Assay for Detection of Patients with Advanced Adenomas
Lahouel, K., Douville, C. B., Diergaarde, B. B., Cohen, J. D., Grant, H., Kuo, A., Ansari, S. K., Wang, Y., Lennon, A. M., Popoli, M., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0398 · Cited by 2
Self-citationAptasensors in colorectal Cancer: Emerging tools for precision diagnostics
Abuhassan, Q., Atoom, A. M., Roopashree, R., Kanwar, J. B., Sudhakar, T., Sharma, V., Chauhan, A. S., & Ruziyev, O. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120751 · Cited by 3
Xie, Z., Wu, Y., Zhou, P., Zhang, Y., LI, X., Li, Y., & Cui, H. (2026) · Talanta · doi:10.1016/j.talanta.2026.130144 · Cited by 2
Progress of Digital PCR for Single DNA Quantification*
Li, L., Sui, Z., Jing, W. A. N. G., Zang, C., & Yu, X. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00003 · Cited by 3
Biomarkers of Lung Cancer: Liquid Biopsy Comes of Age
Miyanaga, A., Masuda, M., & Yamada, T. (2019) · Springer eBooks · doi:10.1007/978-981-13-7295-7_10 · Cited by 3
Benešová, L., Ptáčková, R., Hálková, T., Semyakina, A., Svatoň, M., Fiala, O., Pešek, M., & Minárik, M. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610308 · Cited by 3
Low-cost and clinically applicable copy number profiling using repeat DNA
Abujudeh, S., Zeki, S. S., van Lanschot, M. C. J., Pusung, M., Weaver, J. M. J., Li, X., Noorani, A., Metz, A. J., Bornschein, J., Bower, L., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-08681-8 · Cited by 3
Lu, Q., Guo, Z., Zhang, J., Wang, K., Tian, Q., Liu, S., Li, K., Xu, C., Li, C., Lv, Z., et al. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05027-w · Cited by 2
Calibration of cell-free DNA measurements by next-generation sequencing
Hoerres, D., Dai, Q., Elmore, S., Sheth, S. H., Gupta, G. P., Kumar, S., & Gulley, M. L. (2023) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqad055 · Cited by 2
Role of Circulating Tumor DNA in Colorectal Cancer
Li, H., Lu, S., Zhou, Z., Zhu, X., & Shao, Y. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3346-5_15 · Cited by 2
Wu, G., Song, M., Wang, K., Cui, T., Jiao, Z., Ji, L., Gao, X., Wang, J., Liu, T., Xia, X., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad277 · Cited by 2
Molecular profiling in the management of hepatocellular carcinoma
Soliman, N., Saharia, A., Abdelrahim, M., & Connor, A. A. (2023) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001124 · Cited by 2
Thảo, Đ. T., Thanh, N. P., Quyền, Đ. V., Khai, L. T., Le, S. H., & Trung, N. T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309209 · Cited by 2
Application of plasma cell-free DNA in screening of advanced colorectal adenoma
Chen, B.-H., Ng, H., Liu, Y., Zhang, W., & Wang, G. (2025) · European journal of medical research · doi:10.1186/s40001-025-02313-z · Cited by 2
Ginghină, O., & Niţipir, C. (2018) · InTech eBooks · doi:10.5772/intechopen.72701 · Cited by 2
Lewandowska, M. A., Nalejska, E., Żołna, Ł., Chrząstek, A., Żurawski, B. A., Wiśniewska, M., Las‐Jankowska, M., Roszkowski, K., & Kowalewski, J. (2019) · Współczesna Onkologia · doi:10.5114/wo.2019.85879 · Cited by 3
Deleporte, A., Paesmans, M., Garcia, C. A., Vandeputte, C., Lemort, M., Engelholm, J.-L., Hoerner, F., Aftimos, P. G., Awada, A. H., Charette, N., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-385 · Cited by 2
Cecal Stampede: The Headlong Rush for Screening Colonoscopy: A Position Paper
Lawson, M. J., & Tobi, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9961-7 · Cited by 2
Extracellular Nucleic Acids and Cancer
Fleischhacker, M., & Schmidt, B. (2014) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-017-9168-7_10 · Cited by 2
Circulating Tumor DNA in Blood and Its Utilization as a Potential Biomarker for Cancer
Ondroušková, E., & Hrstka, R. (2015) · Klinicka onkologie · doi:10.14735/amko20152s69 · Cited by 2
Towards the Dreamed Biomarkers?
Ranuncolo, S. M. (2016) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s2-e002 · Cited by 2
Microfluidics for DNA and Protein Analysis with Multiplex Microbead-Based Assays
Yue, W., & Yang, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30019-1_8 · Cited by 2
Ahmedov, B. B., Давыдов, М. М., Керимович, А. А., & Polotskiy, B. E. (2016) · Surgery and Oncology · doi:10.17650/2220-3478-2016-6-3-34-42 · Cited by 2
Shen, Y., Tian, F., Tu, J., Li, R., Chen, Z., Bai, Y., Ge, Q., & Lu, Z. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.03.045 · Cited by 2
Role of Horizontal Gene Transfer in Cancer Progression
Abril, A. G., & Notario, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-21862-1_17 · Cited by 3
Circulating Tumor DNA RASSF1 Methylation for Predicting Cancer Risk: A Diagnostic Meta-Analysis
Sun, X., Li, H., Sun, M., Yuan, Y., & Sun, L. L. (2019) · Future Oncology · doi:10.2217/fon-2019-0219 · Cited by 2
Place des CTC et de l’ADN circulant dans la prise en charge du cancer du sein
Allouchery, V., Augusto, L., & Clatot, F. (2019) · ONCOLOGIE · doi:10.3166/onco-2019-0035 · Cited by 2
Circulating DNA, a Potentially Sensitive and Specific Diagnostic Tool for Future Medicine
Jiang, F., Yang, X., He, X., & Yang, M. (2019) · Dose-Response · doi:10.1177/1559325819891010 · Cited by 2
Development of Novel Pancreatic Tumor Biomarkers
Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_50 · Cited by 2
Georgiadis, K. L., Simpson, K., Ayub, M., Brady, G., Valle, J. W., Jørgensen, C., & Dive, C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_62 · Cited by 2
Froelich, M. F., Schoenberg, S. O., Neumaier, M., & Haselmann, V. (2022) · Journal of Laboratory Medicine · doi:10.1515/labmed-2022-0026 · Cited by 2
The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation
Ren, J., & Liu, R. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3346-5_10 · Cited by 3
Krishnan, R., & Heller, M. J. (2010) · Springer eBooks · doi:10.1007/978-90-481-9382-0_34 · Cited by 2
Liquid biopsy for cancer diagnosis and screening – The promise and challenges
Thorat, M. A. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219837592 · Cited by 2
Liquid Biopsy – Erweiterung des molekularpathologischen Spektrums
Vollbrecht, C. (2020) · best practice onkologie · doi:10.1007/s11654-020-00222-7 · Cited by 2
Noninvasive diagnostic tools in colorectal cancer mass screening
Quintero, E., & Parra‐Blanco, A. (2007) · Current Colorectal Cancer Reports · doi:10.1007/s11888-007-0013-7 · Cited by 2
The Cancer Genome and Diagnostic Blood Tests
Lance, P. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0828 · Cited by 2
Circulating Mitochondrial and Bacterial DNA as Biomarkers of Sepsis
Kisat, M. T. (2016) · UA Campus Repository (The University of Arizona) · Cited by 2
Gene methylation in liquid biopsy and risk of recurrence in lung cancer
Antonellis, P. D., Luca, A. D., & Normanno, N. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.84 · Cited by 2
Low-cost and clinically applicable copy number profiling using repeat DNAPreprint
Abujudeh, S., Zeki, S. S., van Lanschot, M., Pusung, M., Weaver, J. M. J., Li, X., Noorani, A., Metz, A., Bornschein, J., Bower, L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/394429 · Cited by 2
Argonaute-mediated system for supersensitive and multiplexed detection of rare mutationsPreprint
Liu, Q., Guo, X., Xun, G., Li, Z., Chong, Y., Yang, L., Wang, H., Zhang, F., Luo, S., Deng, Z., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/803841 · Cited by 2
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.